| Code |
Definition |
| 1 |
Treatment failure (i.e. virological, immunological, and /or clinical failure) |
| 1.1 |
Virological failure |
| 1.2 |
Partial virological failure |
| 1.3 |
Immunological failure - CD4 drop |
| 1.4 |
Clinical progression |
| 1.5 |
Resistance (based on test result) |
| 2 |
Abnormal fat redistribution |
| 3 |
Concern of cardiovascular disease |
| 3.1 |
Dyslipidaemia |
| 3.2 |
Cardiovascular disease |
| 4 |
Hypersensitivity reaction |
| 5 |
Toxicity, predominantly from abdomen/G-I tract |
| 5.1 |
Toxicity - GI tract |
| 5.2 |
Toxicity - Liver |
| 5.3 |
Toxicity - Pancreas |
| 6 |
Toxicity, predominantly from nervous system |
| 6.1 |
Toxicity - peripheral neuropathy |
| 6.2 |
Toxicity - neuropsychiatric |
| 6.3 |
Toxicity - headache |
| 7 |
Toxicity, predominantly from kidneys |
| 8 |
Toxicity, predominantly from endocrine system |
| 8.1 |
Diabetes |
| 9 |
Haematological toxicity (anemia, etc.) |
| 10 |
Hyperlactataemia/lactic acidosis |
| 11 |
Bone toxicity |
| 15 |
Social contra-indication |
| 16 |
Contra-indication unspecified |
| 16.8 |
Contra-indication expired |
| 16.9 |
Contra-indication - other |
| 17 |
MTCT regimen completed |
| 70 |
Pregnancy - toxicity concerns (during pregnancy) |
| 75 |
Pregnancy - switch to a more appropriate regimen for PMTCT |
| 88 |
Death |
| 90 |
Side effect - any of the above not mentioned |
| 90.1 |
Comorbidity |
| 91 |
Toxicity - other (not mentioned above) |
| 91.1 |
Toxicity - unspecified |
| 92 |
More effective treatment available |
| 92.1 |
Simplified treatment available |
| 92.2 |
Treatment too complex |
| 92.3 |
Drug interaction |
| 92.31 |
Drug interaction - commencing TB/BCG treatment |
| 92.32 |
Drug interaction - ended TB/BCG treatment |
| 92.33 |
Change in eligibility criteria (e.g. child old enough for tablets; refrigerator no longer available) |
| 92.4 |
Protocol change |
| 92.5 |
Regular treatment termination (used in tblMED e.g. for DAAs against HCV, antibiotics) |
| 92.6 |
End of empiric therapy |
| 92.9 |
Change in treatment not due to side-effects, failure, poor adherence or contra-indication |
| 92.91 |
Change to a generic drug |
| 92.92 |
Change to branded drug |
| 93 |
Structured Treatment Interruption (STI) |
| 93.1 |
Structured Treatment Interruption (STI)-at high CD4 |
| 94 |
Patient's wish/ decision, not specified above |
| 94.1 |
Non-compliance |
| 94.2 |
Defaulter |
| 95 |
Physician's decision, not specified above |
| 96 |
Pregnancy |
| 96.1 |
Pregnancy intended |
| 96.2 |
Pregnancy ended |
| 97 |
Study treatment |
| 97.1 |
Study treatment commenced |
| 97.2 |
Study treatment completed |
| 97.6 |
Drug not available |
| 98 |
Other causes, not specified above |
| 99 |
Unknown |
Download CSV )
Last code list update: 2019-10-14